Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. We are a platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies. We work on rare vascular diseases as well as more common indications effecting large patient populations.
| Website | http://www.ambulero.com |
| Employees | 3 (0 on RocketReach) |
| Founded | 2019 |
| Address | 1951 NW 7th Ave Ste. 600, Miami, Florida 33136, US |
| Industry | Biotechnology Research |
Looking for a particular Ambulero employee's phone or email?
Ambulero is based in Miami, Florida.